This is a snippet of the transcript.Contact Salesto get full access.
Magnite is saying, "If I start," and everyone's doing this, "we need to be on the sell side. We're here for the sell side and targeting for them, and we're a big part." But with this ClearLine thing we're building, we're talking to the buyers because The Trade Desk is getting really big and scary. We don't want that Google situation again where there's super control. We can cut into those margins a bit more.
This is a snippet of the transcript.Contact Salesto get full access.
So now, instead of Magnite only getting a 10% or 12% take rate, maybe they can get 15%, 17%, or 20% if they own the buy side as well. The margins in the middle are starting to be played with, where more money is going to these supply side and demand side partners. The Trade Desk is doing the exact same thing with OpenPath. PubMatic is doing the same with their direct line. Viant is doing the same with Viant Direct Access. They're all trying to get into the margins as much as possible.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research